AB Science S.A (AB) — Cash Flow-to-Debt Ratio
AB Science S.A (AB) has a Cash Flow-to-Debt Ratio of -0.01x as of December 2025, meaning its operating cash flow of €-207.00K could theoretically repay 0% of its total liabilities (€34.34 Million) in one year. See AB FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
AB Science S.A Cash Flow-to-Debt Ratio (2009–2025)
Historical debt coverage capacity for AB Science S.A across 17 annual periods. For the full cash flow conversion analysis, see AB cash flow conversion.
Annual Cash Flow-to-Debt Ratio for AB Science S.A (2009–2025)
Year-by-year debt coverage analysis for AB Science S.A. Check AB Science S.A cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.12x | €-4.29 Million | €34.34 Million | ▼ -1216.4% |
| 2024 | 0.01x | €525.00K | €46.93 Million | ▲ +103.1% |
| 2023 | -0.36x | €-16.87 Million | €46.51 Million | ▼ -23.6% |
| 2022 | -0.29x | €-17.47 Million | €59.51 Million | ▲ +24.0% |
| 2021 | -0.39x | €-17.18 Million | €44.47 Million | ▼ -40.8% |
| 2020 | -0.27x | €-13.51 Million | €49.24 Million | ▲ +19.3% |
| 2019 | -0.34x | €-15.16 Million | €44.57 Million | ▲ +52.5% |
| 2018 | -0.72x | €-26.79 Million | €37.45 Million | ▼ -24.6% |
| 2017 | -0.57x | €-22.90 Million | €39.87 Million | ▲ +26.8% |
| 2016 | -0.78x | €-33.52 Million | €42.72 Million | ▼ -68.9% |
| 2015 | -0.46x | €-23.16 Million | €49.84 Million | ▼ -54.1% |
| 2014 | -0.30x | €-14.16 Million | €46.96 Million | ▼ -1.7% |
| 2013 | -0.30x | €-12.84 Million | €43.29 Million | ▼ -19.7% |
| 2012 | -0.25x | €-6.21 Million | €25.08 Million | ▲ +35.3% |
| 2011 | -0.38x | €-8.32 Million | €21.73 Million | ▲ +28.8% |
| 2010 | -0.54x | €-7.86 Million | €14.62 Million | ▲ +9.6% |
| 2009 | -0.60x | €-7.77 Million | €13.04 Million | — |